UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058762
Receipt number R000067190
Scientific Title Efficacy of Contact Needle Therapy (Non-insertive Acupuncture, CNT) for Night Crying in Infants and Toddlers: A Crossover Trial
Date of disclosure of the study information 2025/08/12
Last modified on 2025/08/11 23:05:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of Contact Needle Therapy (Non-insertive Acupuncture, CNT) for Night Crying in Infants and Toddlers: A Crossover Trial

Acronym

Efficacy of Contact Needle Therapy (Non-insertive Acupuncture, CNT) for Night Crying in Infants and Toddlers: A Crossover Trial

Scientific Title

Efficacy of Contact Needle Therapy (Non-insertive Acupuncture, CNT) for Night Crying in Infants and Toddlers: A Crossover Trial

Scientific Title:Acronym

CNT-NC Trial

Region

Japan


Condition

Condition

nighttime crying

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objective of this study is to evaluate the efficacy and safety of contact needle therapy for night crying in infants and toddlers. Using a crossover trial design, the intervention period with contact needle therapy will be compared with a non-intervention period to assess changes in indicators such as the frequency of nighttime awakenings, duration of crying, and parental childcare-related stress. These outcomes will be evaluated using questionnaires and an actigraph.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Between-group comparison of sleep duration and sleep depth measured using the wGT3X-BT monitor (Acti Japan Co., Ltd.)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Infants and toddlers aged 6 to 48 months attending the Tanpopo Nursery School, Hiroshima University

Interventions/Control_2

After obtaining informed consent, participants will be randomly assigned to either the early intervention group, which begins acupuncture treatment immediately after the start of the trial, or the late intervention group, which begins treatment two weeks after the trial starts. The treatment period consists of pediatric acupuncture administered three times per week for two weeks, for a total of six sessions. The treatment will be performed on the whole body following standard pediatric acupuncture techniques. An actigraph will be worn before and after the treatment period to record sleep data. In addition, the participants parents or guardians will be asked to complete questionnaires before and after the treatment period.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

6 months-old <=

Age-upper limit

48 months-old >=

Gender

Male and Female

Key inclusion criteria

1. Infants and toddlers aged 6 to 48 months attending the Tanpopo Nursery School, Hiroshima University

2. Children without sleep-disrupting diseases or other health problems, who are considered to have night crying (waking up crying at night three or more times per week)

3. Children not receiving other acupuncture or moxibustion treatments

4. Children whose parents or guardians have provided written informed consent after receiving an adequate explanation of the study

Key exclusion criteria

1. Children with any of the following comorbidities:
Congenital diseases
Seizures or paroxysmal disorders
Heart diseases

2. Children deemed unsuitable by the principal investigator or co-investigators for any other reason

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Yoshihiro
Middle name
Last name Tamura

Organization

Kampo Clinical Center, Hiroshima University Hospital

Division name

Kampo Clinical Center, Hiroshima University Hospital

Zip code

7348551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima City, Hiroshima Prefecture

TEL

082-257-1921

Email

ytamura0@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Maiko
Middle name
Last name Chiyokori

Organization

Kampo Clinical Center, Hiroshima University Hospital

Division name

Kampo Clinical Center, Hiroshima University Hospital

Zip code

7348551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima City, Hiroshima Prefecture

TEL

082-257-1921

Homepage URL


Email

chiyoman@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima University Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hiroshima University Hospital

Address

1-2-3 Kasumi, Minami-ku, Hiroshima City, Hiroshima Prefecture

Tel

0822575555

Email

hugcp@hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 08 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 08 Month 15 Day

Date of IRB


Anticipated trial start date

2025 Year 09 Month 01 Day

Last follow-up date

2026 Year 04 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 08 Month 11 Day

Last modified on

2025 Year 08 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067190